Identification of a Nucleoside Analog Active Against Adenosine Kinase–expressing Plasma Cell Malignancies

Journal of Clinical Investigation - United States
doi 10.1172/jci83936
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Clofarabine, a Novel Nucleoside Analog, Is Active in Pediatric Patients With Advanced Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Design of an Adenosine Phosphorylase by Active-Site Modification of Murine Purine Nucleoside Phosphorylase

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1999English

Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase

Cell
BiochemistryGeneticsMolecular Biology
2017English

Molecular Imaging of Active Mutant L858R EGF Receptor (EGFR) Kinase-Expressing Nonsmall Cell Lung Carcinomas Using PET/CT

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

CMCdG, a Novel Nucleoside Analog, Exerts Potent Activity Against Wild-Type and Entecavir-Resistant HBV With Favorable Safety Feature

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

An Analog-Sensitive Version of the Protein Kinase Slt2 Allows Identification of Novel Targets of the Yeast Cell Wall Integrity Pathway

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Transcriptional Analysis of the Human IgE-Expressing Plasma Cell Differentiation Pathway

Frontiers in Immunology
AllergyImmunology
2019English

Identification and Characterization of a Cell-Surface Receptor, P2Y15, for AMP and Adenosine

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Adenosine Kinase Inhibition Selectively Promotes Rodent and Porcine Islet -Cell Replication

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy